ExploreWatchlistsPricing
  1. US-listed companies
  2. BRAINSTORM CELL THERAPEUTICS INC.
  3. Financials
  4. Research & development

BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Market cap
$11.03M
P/E ratio
SummaryFinancials
Period EndResearch & development (Million USD)YoY (%)
Dec 31, 20254-10.23%
Dec 31, 20245-56.72%
Dec 31, 202311-23.00%
Dec 31, 202214-8.40%
Dec 31, 202115-31.77%
Dec 31, 202022+892.40%
Dec 31, 20162-54.54%
Dec 31, 20155+3.71%
Dec 31, 20145-83.60%
Dec 31, 201329+11.14%
Dec 31, 201226+7.25%
Dec 31, 201124

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat